NCT01235988已完成不适用
Systematic Review of the Clinical and Cost Effectiveness of Treatments for Idiopathic (Immune) Thrombocytopenic Purpura (ITP): Direct Meta Analysis
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1
- 主要终点
- >=50 Gi/L platelet count to <400 Gi/L
研究概览
简要总结
The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care)
详细描述
Meta-analysis of three studies: Bussell 2007 & Bussell 2009 & RAISE (TRA102537).
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults with ITP
- •Received a pre-specified treatment
- •Prospective clinical studies with at least 10 patients
排除标准
- •Subjects with ITP due to other causes
研究组 & 干预措施
Eltrombopag & standard of care
干预措施: Eltrombopag (Drug)
Standard of care
干预措施: Placebo (Drug)
结局指标
主要结局
>=50 Gi/L platelet count to <400 Gi/L
时间窗: 43 days
次要结局
未报告次要终点
研究者
相似试验
已完成
3 期
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.Idiopathic Thrombocytopenic PurpuraNCT01520909GlaxoSmithKline92
招募中
4 期
Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in AdultsPrimary Immune Thrombocytopenia (ITP)NCT04518475Institute of Hematology & Blood Diseases Hospital, China224
进行中（未招募）
2 期
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction ChemotherapyAcute Myeloid LeukemiaNCT03603795French Innovative Leukemia Organisation110
已完成
3 期
Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390Hepatitis CNCT00996216GlaxoSmithKline27
已完成
3 期
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive ProceduresChronic Liver DiseaseThrombocytopeniaNCT02389621Shionogi215